Member Info for bamb

which smart ass brought 1 share then :)

some odd trades today? are mm's speaking in code or something'?

me too...i'm no financial expert by any means...but this is such a compelling investment and hopefully all of us about to be rewarded for our patience,

We were all saying how undervalued this was last year...but now with the BOAGF establishing itself and proven with interest rates of 10-14%, the AGI (which sounds like it could be become Alpha's key prong) about to target clients and news on the RCF and given the economic landscape for the next few years, this share deserves a rerate...Just need Gobind to deliver now.

yes demand for my shares most of the morning. Wouldn't be surprised to see another TR1 pop up. Perhaps Mr Ward still peckish here.

yes, that but stuck out for me too....one of the main obstacles to growth is the ignorance of the policy holder that they can cash it in early.

MPG sees several key drivers of growth in the US’ life settlement market, including:

Investors are seeking above-average returns in the current low interest rate environment
The regulatory environment governing life settlements is established now and new legislation continues to support market growth. Several states are making it compulsory for insurers to inform policyholders wishing to lapse their policies that there are more lucrative opportunities to settle instead, for example

An increasing number of baby boomers are seeking ways to pay for retirement or care. The US Census Bureau predicts a 37% increase in those aged 65 years and older to 78m by 2035, for example

Retirees relying on income from savings have been badly affected by low interest rates that have depleted income and caused erosion of capital.

The increase in unemployment and negative impact on retirement funds caused by the COVID pandemic will spur more policyholders to sell their policies

The life settlement market is set to continue its five-year boom in 2021 as investors seek alternatives to fully priced bonds and volatile equities, according to Managing Partners Group (MPG), the international asset management group. Life settlements are US-issued life insurance policies that have been sold by the original owner at a discount to their future maturity value and are institutionally traded through a highly regulated secondary market.

The asset class is seeing increasing interest from institutional investors and wealth managers in the US, Europe – especially Switzerland – and Asia, says MPG, which estimates that the face value of new policies coming onto the market is set to increase by 10% in 2020 to $4.6bn and this will rise to $5bn in the New Year.(1)

The volume of new life settlements coming on to the market has risen annually since 2016, when investors began showing renewed interest in the asset class, although it is still some way below the peak of $12.2bn seen in 2007. The total face value of in-force life settlements was estimated to be $21.6bn in 2019.

Gan Wyndham-Jones, MPG’s Head of Investments, commented: “The volume of enquiries and interest we are receiving from investors has increased dramatically in Q2 and Q3 this year, especially from asset managers that are looking to diversify from core asset classes to preserve value and increase balance in their client portfolios, and to identify alternatives that have the potential to deliver more reliable future capital growth.

“Many asset managers have preferred in recent years to limit their exposure to equities and fixed income, which performed very well up to the end of 2019 but then COVID-19 triggered the correction that equity markets were due during Q1 of 2020. The challenge for investors now is to guess how significant the economic impact of the virus will be.”

MPG analysis(2) shows that life Settlements currently offer high Internal Rates of Return (IRR) of around 13% because of the discounts at which they can be purchased versus their fixed maturity values. Discount rates narrowed in 2020 as demand rose but they are still in a range of between 12.5% and 13.5%.

that target by Swick was talked about in 2018. Two years later a lot has changed and all for the better. 30p should very quick once AUM exceeds 100-150mn and all the other pieces start to come together. Achieving the RCF will in itself be a game changer. Covid stocks will very soon fall out of fashion but I can't see the rest of the market recovering fully for another 6-12 months. If that, unemployment is going to keep on rising for the foreseeable future. More and more people in the US will want to see their life insurance policies. Which leads to where will money move to in 2021? Non-correlated stocks with plenty of growth potential. Does anyone know any ? :)

and can still sell 20K worth without NT...Could those investing directly into the black oak fund for a client also be buying in here?

whilst BOAGF is finally accruing investment, I am very interested how the AGI fund starts...I'm no expert by any means, but looks like the ducks are finally lining up

I'm with you on the free float...and mm's will have their work cut out to free up some churn here until 10p +

brought some more last week....had a reread of the last corporate update. Should hit $100mn AUM for the BOAGF in H1 2021 at latest. Returns up to 14% going to start attracting some serious money. RCF confirmation any time soon...AGI sounds interesting too https://www.youtube.com/watch?v=kcIFrpr5qIQ

A firm owned by Remote Monitored Systems (RMS) will begin producing anti-viral face masks in January.

Pharm2Farm's masks are designed to kill coronavirus on impact.

RMS's core focus is operating drones that check railway lines and big factories for damage, but it bought Pharm2Farm in August.

Despite providing investors with an up-to-date timetable for production, shares in AIM-listed RMS slumped 25.5 per cent, or 0.65p, to 1.9p.

could sell 1mn at the end...news or not should see another push up. Alpha likes to do a end of the year surge. We hit 4p at the end of 2018, nearly 3p at the end of last year. It is almost a year (December 2nd) since Gobind announced the RCF.

can sell 500K for 1.66. Reckon 2p by COP

thanks to 2mex for this...

1. The Black Oak Alpha Growth Fund has demonstrated its performance resilience on course to provide a return within the 10% to 14%.
2. Going into 2021, record low interests rates look set to continue making the BOAG more attractive.
3. Approx £450K raised in August and some income already coming in from fund.
4. Alpha has probably the top life settlements market maker, Danny Swick, with $8Billion of trading experience.
5. Alpha with SLIM has in-house actuarial expertise specific to life policies - a quality not found in usual settlement businesses
6. The above two points are validated in the progress towards $100million credit facility
7. Points 4&5 are inlet and processing. Austin King, with extensive connections has been brought in for the outlet; the sales.
8. KPMG has validated a 16.2% annualised return on this uncorrelated asset
9. "this uncorrelated asset": the asset class is not affected by general market
10. Alpha has structured a tax-efficient system which will bring in global investors
11. Black Oak fund has already received commitments for seed capital of $15 million
12. The market is absolutely massive at $19Trillion with $57Billion policies lapsing each year
13. Only $2.8Billion of policies are settled each year. The $57Billion lapsing is there to be taken.
14. The market will climb over the next 10years as baby boomers retire
15. Note the wave retiring is more tech-savvy, internet dependent: ideal for targeted marketing
16. Point 15 also means that social media / marketing will build life settlement awareness
17. Perhaps THE key point: Life settlement is a great option, far better than surrender or lapsing
18. The $100million credit facility can be used to buy $500m of face value and repeated 4x per year
19. Alpha has a unique situation with specific talents amalgamated for Life Settlement
20. Legislation is already present in 6 states to ensure life policy holders are made aware of the settlement option.
21. This is a scalable, low overhead business which has potential ahead to 10bag, 20bag etc.
22. Based on the projected targets Y1:FUM $100m, Y2:FUM $350m etc, the projected FUM after 8 years will be approaching $8 Billion
23. Potential for asset manager(s) to increase credit facility
24. The initial $100m trade target for year 1 indicates confidence of business developing quickly. After Y2, expected annual increment more than $250m
25. When asked about 3-5 year target/valuation: Danny Swick's reply "..Yes, I think the ultimate goal which I think about on a regular basis is where we get to a point where we have a market cap in excess of $100million.."
26. "..The life settlements market could experience a double-digit compound gross market annual growth rate (CAGR) over the next decade, according to a forecast from investment management consultancy Conning.."
"..By 2028, Conning expect the market to have seen an impressive $212 billion of life settlements, while on an annual is

added more. just in time by the looks of it. RCF news?

oh and until recently (and perhaps even now) they used mercury in vaccines and now they use Aluminium...WTF! Given the speed of these latest vaccines, who knows what they have been using to make it work...IMO we need 2-3 years before mass inoculations...maybe more for the vaccines using brand news technology....

NO! I'm a vegetarian.